We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to use an interrupted time series to evaluate your digital health product.
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
Scientific opinion from the UK Nutrition and Health Claims Committee (UKNHCC) for the substantiation of an Article 14(1)(a) health claim: Morus alba leaf extract and blood glucose levels.
Information for clinicians on diagnosis and notification of Shiga toxin-producing Escherichia coli (STEC) and haemolytic uraemic syndrome (HUS).
Advice for healthcare professionals on how to use blood glucose meters safely and effectively.
You can claim relief to pay no Customs Duty and VAT if you're importing therapeutic substances of human origin, blood-grouping or tissue-typing reagents, or related packaging, solvents and accessories.
How to use a cost effectiveness analysis to evaluate your digital health product.
TACO is one of the most common causes of transfusion-related deaths in the UK and cases have increased substantially in recent years. Identifying risk factors for TACO prior to transfusion allows initiation of appropriate mitigating measures.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Data analysis was performed using the chi-square test and multivariate logistic regression
What blood establishments, blood banks and manufacturers of blood products need to do to ensure the safety and quality of blood and blood products.
Information and guidance on a range of medical devices for users and patients.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
This study reported high prevalence, especially of undiagnosed cases amongst adults, most have uncontrolled blood sugar levels
Find out how to access additional support services including those from the existing Infected Blood support schemes, charities and NHS.
Information on depleted uranium (DU) including what it is, its uses, health effects and protection from exposure.
Information about ensuring blood and blood component safety.
Information and service documents on the national DBS testing service offered by PHE to improve uptake of 12 month testing of infants born to hepatitis B infected mothers.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).